Prosthesis-patient mismatch in transcatheter and surgical aortic valve replacement.
Transcatheter aortic valve replacement (TAVR)
prosthesis-patient mismatch (PPM)
surgical aortic valve replacement (SAVR)
Journal
Annals of cardiothoracic surgery
ISSN: 2225-319X
Titre abrégé: Ann Cardiothorac Surg
Pays: China
ID NLM: 101605877
Informations de publication
Date de publication:
31 May 2024
31 May 2024
Historique:
received:
07
10
2023
accepted:
20
03
2024
medline:
6
6
2024
pubmed:
6
6
2024
entrez:
6
6
2024
Statut:
ppublish
Résumé
Prosthesis-patient mismatch (PPM) occurs when the effective orifice area (EOA) of a normally functioning prosthetic valve is too small in relation to the patient's body size. The effect of PPM on outcomes and valve durability have gained credibility, making this an important possibly preventable risk factor. Transcatheter aortic valve replacement (TAVR) generally has a lower incidence of PPM than surgical aortic valve replacement (SAVR). Current surgical literature and randomized trials show an association between severe PPM and mortality in patients with SAVR but there is less evidence for an association with TAVR. Differences in the incidence of PPM may be related to the methods and cutoffs for measuring mismatch. This review will discuss the current state of field and propose standardization of measurement methods which may more accurately risk stratify patients.
Identifiants
pubmed: 38841078
doi: 10.21037/acs-2023-aae-0166
pii: acs-13-03-211
pmc: PMC11148757
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
211-223Informations de copyright
2024 Annals of Cardiothoracic Surgery. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: R.T.H. is Echo Core Lab Director for multiple transcatheter aortic valve replacement trials for which she receives no direct compensation. P.P. is Echo Core Lab Director for multiple transcatheter aortic valve replacement trials for which he receives no direct compensation.